Heritage Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,577
Closed -$128K 596
2025
Q1
$128K Hold
1,577
0.01% 227
2024
Q4
$142K Hold
1,577
0.01% 230
2024
Q3
$156K Buy
+1,577
New +$155K 0.01% 231

Other funds holding XBI

Heritage Wealth Advisors's XBI Position: Q2 2025 in Review

Heritage Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 1,577 shares — an estimated $128K sold.

Heritage Wealth Advisors first reported a position in XBI in Q3 2024 and held it in 3 quarters. The position peaked at $156K in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Heritage Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Heritage Wealth Advisors sold 1,577 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $128K.
  • Heritage Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and held it in 3 quarters.
  • Heritage Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $156K in Q3 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Heritage Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.